NextCell Pharma ABNXTCL 
$0.120.79%24h
0.79%24h
Global rank34881
Market cap$4.29M
Change 7d4.92%
YTD Performance-51.33%
SP500 benchmarkUnderperform
P/E-0.11
P/S4.35
Revenue$986.68K
Earnings-$3.88M
Dividend yield-
Main Sector
Healthcare
Category
NextCell Pharma AB NXTCL Operating Margins
Operating Margin in 2022: -4.05%
According to NextCell Pharma AB latest financial reports the company has an operating margin of -4.05%, an decrease of -35.31% to 2022. At the end of 2022 company had an operating margin of -6.27%.
NextCell Pharma AB Operating Margin from 2020 to 2024
-
Value:-
NXTCL Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -4.05% | -35.31% |
| 2022 | -6.27% | -1.23% |
| 2021 | -6.34% | 27.76% |
| 2020 | -4.97% | - |
View the highest operating margin companies 
